Robert G. Price

Stockley Park
Uxbridge, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial.

Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial.

Journal: Journal of clinical pharmacology

Published: August 22, 2025

Automated household-based water disinfection system for rural communities: Field trials and community appropriation.

Automated household-based water disinfection system for rural communities: Field trials and community appropriation.

Journal: Water research

Published: March 29, 2025

Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study.

Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study.

Journal: Annals of medicine

Published: October 28, 2024

Prospective REALITI-A Study: 2-Year Real-World Benefits of Mepolizumab in Severe Asthma.

Prospective REALITI-A Study: 2-Year Real-World Benefits of Mepolizumab in Severe Asthma.

Journal: CHEST pulmonary

Published: September 16, 2024

Utilisation and valorisation of distillery whisky waste streams via biomass electrolysis: electrosynthesis of hydrogen.

Utilisation and valorisation of distillery whisky waste streams via biomass electrolysis: electrosynthesis of hydrogen.

Journal: Faraday discussions

Published: July 21, 2023

Measuring behaviour in hens using an ethogram to assess analgesia during further refinement of a high welfare, on-hen, poultry red mite feeding device.

Measuring behaviour in hens using an ethogram to assess analgesia during further refinement of a high welfare, on-hen, poultry red mite feeding device.

Journal: F1000Research

Published: May 19, 2023

Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis.

Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis.

Journal: The journal of allergy and clinical immunology. In practice

Published: January 23, 2023

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study.

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study.

Journal: Frontiers in immunology

Published: January 23, 2023

New perspectives in application of kidney biomarkers in mycotoxin induced nephrotoxicity, with a particular focus on domestic pigs.

New perspectives in application of kidney biomarkers in mycotoxin induced nephrotoxicity, with a particular focus on domestic pigs.

Journal: Frontiers in microbiology

Published: October 31, 2022

Evaluation of the performance of a lateral flow device for quantitative detection of anti-SARS-CoV-2 IgG.

Evaluation of the performance of a lateral flow device for quantitative detection of anti-SARS-CoV-2 IgG.

Journal: Clinical immunology communications

Published: September 02, 2022

Nephrotoxic Biomarkers with Specific Indications for Metallic Pollutants: Implications for Environmental Health.

Nephrotoxic Biomarkers with Specific Indications for Metallic Pollutants: Implications for Environmental Health.

Journal: Biomarker insights

Published: January 07, 2022

The role of urinary N-acetyl-β-D-glucosaminidase in early detection of acute kidney injury among pediatric patients with neoplastic disorders in a retrospective study.

The role of urinary N-acetyl-β-D-glucosaminidase in early detection of acute kidney injury among pediatric patients with neoplastic disorders in a retrospective study.

Journal: BMC pediatrics

Published: January 03, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026